Outlook Therapeutics competitors

View the competitive landscape for Outlook Therapeutics, featuring companies like Kalaris Therapeutics, Novartis, and Roche. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Outlook Therapeutics

Late-stage biopharmaceutical company developing ophthalmic bevacizumab

List of Outlook Therapeutics competitors

Kalaris Therapeutics

Clinical-stage biopharmaceutical company developing retinal disease treatments
kalaristx.com
Novartis

Pharmaceutical firm marketing various treatments for neovascular age-related macular degeneration
novartis.com
Roche

Global healthcare company providing innovative biologics for wet AMD treatment
roche.com
Regeneron

Biotechnology company manufacturing leading anti-VEGF therapies for retinal disorders
regeneron.com
Merck

Biotechnology company advancing clinical programs for diabetic macular edema
merck.com
REGENXBIO

Clinical-stage biotechnology company developing gene therapies for retinal conditions
regenxbio.com
EyePoint Pharmaceuticals

Company developing sustained-release therapeutics for serious retinal diseases
eyepoint.bio
Adverum Biotechnologies

Clinical-stage gene therapy company targeting ocular and rare diseases
adverum.com
Kodiak Sciences

Clinical-stage company developing antibody biopolymer conjugates for retinal diseases
kodiak.com
Ocular Therapeutix

Biopharmaceutical company focused on hydrogel-based formulations for eye conditions
ocutx.com
Opthea

Biopharmaceutical company developing VEGF-C/D trap therapies for wet AMD
opthea.com

Track Outlook Therapeutics & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.

Browse competitors related to Outlook Therapeutics and other trending companies.